Security record · archived quarter
GSK
GSK plc · Healthcare · Drug Manufacturers - General
2Tracked holders
0Δ holders
163.18KShares held
$7.64MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 163.18K | $7.64M | n/a | n/a |
| Q2 2026 | 115 | +1 | 291.71M | $15.16B | +8 | −8 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | n/a |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | n/a | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | n/a | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | n/a |
| Q2 2024 | 12 | n/a | 118.47M | $4.56B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 100.53K | -12.5% | $4.68M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 62.65K | +51.9% | $2.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,022 holders, 373.63M shares, $18.86B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API